drugset / Trial / NCT02171039
Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To investigate the bioavailability of dabigatran with and without concomitant administration of atorvastatin and the bioavailability of atorvastatin with and without concomitant administration of dabigatran etexilate
Timeline
- Start
- 2006-06
- Primary completion
- 2006-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 80 mg | Oral |
| Subject | Dabigatran | Unknown | 150 mg | Oral |
Indications
No indication recorded.